Virometix AG
... immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. ... immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. ...
UZH - CRPP ImmunoCure - Miachael Weller
... immunotherapeutic agents in brain tumors. Furthermore, novel treatment strategies are assessed in patients with ... newly diagnosed and recurrent glioblastoma. Overcoming resistance of gliomas to immunotherapeutic ... chemo- and immunotherapeutic agents in brain tumors. Furthermore, novel treatment strategies are ... immunotherapeutic strategies Development of novel drugs in early clinical trials Design and conductance of late ...
UZH - CRPP ImmunoCure - Patrick Roth
... : University Hospital Zurich Department of Neurology Frauenklinikstrasse 26 CH-8091 Zurich Immunotherapeutic ... the immune system with a particular focus on novel immunotherapeutic strategies. The following ... Department of Neurology Frauenklinikstrasse 26 CH-8091 Zurich patrick.roth@usz.ch Immunotherapeutic ... the immune system with a particular focus on novel immunotherapeutic strategies. The following ...
Emerging immunotargets and immunotherapies in prostate cancer - Zur...
... progression. On this scenario, several immunotherapeutic approaches have been proposed and are presently under ... focused on emerging immunotherapeutic approaches in patients with PCa, showing the rational for their ... cancer (PCa) carcinogenesis and progression. On this scenario, several immunotherapeutic approaches have ... or in combined strategies. In this review, we focused on emerging immunotherapeutic approaches in ...
UZH - CRPP ImmunoCure
... immunotherapeutic strategies for various types of cancer including brain tumors and hematological malignancies. A ... groups aiming at the development of novel immunotherapeutic strategies for various types of cancer ... CAR T cells and other antibody-based immunotherapeutic strategies in appropriate preclinical models ...
5th Zurich Immuno-Oncology Symposium – Universitätsspital Zürich
... development of new immunotherapeutic agents requires a multidisciplinary approach. Standort 16.30-18:30 Uhr ... development of new immunotherapeutic agents requires a multidisciplinary approach. Standort Virtual Live ...
UZH - CRPP ImmunoCure - Organization
... -lasting expertise in brain tumors and the development of novel immunotherapeutic approaches against these ... and the development of novel immunotherapeutic approaches against these tumors. The group of Prof ... . César Nombela-Arrieta, PhD. Prof. Novel immunotherapeutic concepts Dario Neri, PhD. Prof. Fusszeile top ...
UZH - CRPP ImmunoCure - Research
... immunotherapeutic platform” in Zurich that includes (i) monoclonal antibody engineering, (ii) CAR cell engineering ... immunotherapeutic platform” in Zurich that includes (i) monoclonal antibody engineering, (ii) CAR cell engineering ...
UZH - CRPP ImmunoCure - Markus Manz
... Markus G. Manz, Prof. Dr. med. Phone: +41 (0)44 255 38 99 Immunotherapeutic approaches against ... will advance the development of novel immunotherapeutic agents for the treatment of hematopoietic stem ... . Dr. med. Phone: +41 (0)44 255 38 99 markus.manz@usz.ch Immunotherapeutic approaches against ... will advance the development of novel immunotherapeutic agents for the treatment of hematopoietic stem ...
New Portfolio Start-Up: Stromal Therapeutics – USZ
... stroma. Stromal Therapeutics is developing novel Immunotherapeutic medicines to treat chronic ... developing novel Immunotherapeutic medicines to treat chronic inflammatory diseases. With their unique domain ...
